Year To Quarter End Consolidated Statement Of Comprehensive Income

Astellas Pharma Inc. - Filing #7258550

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
JPY
JPY
JPY
319,719,000,000 JPY
319,719,000,000 JPY
JPY
319,719,000,000 JPY
JPY
JPY
JPY
319,719,000,000 JPY
JPY
JPY
JPY
JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
JPY
JPY
JPY
292,161,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.